1、Click here or press enter for the accessibility optimised versionThe Future ofHealthtech 2022Click here or press enter for the accessibility optimised versionExecutive SummaryIn just the past nine months,the healthtechindustry has seen dramatic shifts.Venturecapital investment and deal pace are slow

2、ingfrom their peak in 2021,with valuationslowering and check sizes decreasing.Rising interest rates,inflation and globalgeopolitical factors all created record marketvolatility.Public healthtech companies sawtheir shares drop at record paces.These shifts all indicate a healthtech marketreset is unde

3、rway.Weve moved from agrowth-at-all-costs era to an era thatemphasizes clear value creation,whether itsthrough improving health outcomes,access,or affordability.Investment has shifted into earlier stageswhere valuations are corrected from lastyears sky-high levels.With a record amountof dry powder a

4、vailable to healthtechstartups,and mergers and acquisitions onthe rise,there is still a tremendousopportunity for healthtech companies togrow.The healthcare industry,presenting new andemerging challenges in 2022,remains ripefor innovation and is more resilient duringperiods of downturn.Looking forwa

5、rd,healthtech companies willneed to focus on delivering measurable valueto continue driving innovation.The Future of Healthtech 2022Market reset from 2021s blockbuster levels marked by flight to quality and early-stage investmentI think this is one ofthe best times to bestarting a companyand one of

6、the besttimes to be buildingresponsibly.Hemant Taneja,Managing Partner General CatalystTable of ContentsHealthtech Market HighlightsHealthtech Investment OverviewSpotlight:Mental HealthSector to Watch:Womens HealthHealthtech Subsector Trends and PredictionsHealthtech Global ExitsClick here or press